Erion Dobi
Impact in
-
- Breast Cancer Treatment Studies
-
- Colorectal Cancer Treatments and Studies
- Cancer survivorship and care
- Cancer Treatment and Pharmacology
Papers in
- Oncology 15
- Cancer Treatment and Pharmacology 4
- Colorectal Cancer Treatments and Studies 4
- Cancer Immunotherapy and Biomarkers 2
-
- Breast Cancer Treatment Studies 6
- Co-authors
- Xavier B. Pivot (22 shared papers)L. Chaigneau (20 shared papers)Fernando Bazán (15 shared papers)Antoine Thiery-Vuillemin (11 shared papers)Stefano Chong Hun Kim (8 shared papers)Cristian Villanueva (11 shared papers)Martin Demarchi (7 shared papers)Thierry Nguyen (8 shared papers)
In The Last Decade
Erion Dobi
30 papers receiving 363 citations
Peers
Comparison fields: 5 of 53
- Cancer Research 84
- Oncology 117
- Drug Discovery 1
- Pulmonary and Respiratory Medicine 57
- Biomaterials 16
Countries citing papers authored by Erion Dobi
This map shows the geographic impact of Erion Dobi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erion Dobi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erion Dobi more than expected).
Fields of papers citing papers by Erion Dobi
This network shows the impact of papers produced by Erion Dobi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erion Dobi. The network helps show where Erion Dobi may publish in the future.
Co-authors
The 25 scholars most cited alongside Erion Dobi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 49 | |
| 2 | 2012 | 37 | |
| 3 | 2011 | 25 | |
| 4 | 2015 | 22 | |
| 5 | 2022 | 20 | |
| 6 | 2013 | 19 | |
| 7 | 2014 | 19 | |
| 8 | 2015 | 18 | |
| 9 | 2016 | 17 | |
| 10 | 2012 | 15 | |
| 11 | 2013 | 15 | |
| 12 | 2019 | 15 | |
| 13 | 2012 | 14 | |
| 14 | 2015 | 13 | |
| 15 | 2013 | 9 | |
| 16 | 2014 | 9 | |
| 17 | 2025 | 7 | |
| 18 | 2022 | 6 | |
| 19 | 2012 | 5 | |
| 20 | 2023 | 5 |
About Erion Dobi
Erion Dobi is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Gastroenterology and Anesthesiology and Pain Medicine, having authored 33 papers that have together received 370 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (6 papers), Prostate Cancer Treatment and Research (4 papers), Cancer Treatment and Pharmacology (4 papers), Colorectal Cancer Treatments and Studies (4 papers), Cancer Immunotherapy and Biomarkers (2 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers), Advanced Breast Cancer Therapies (2 papers) and Brain Metastases and Treatment (2 papers). The work is most often cited by research in Cancer Research (84 citations), Oncology (117 citations), Drug Discovery (1 citation), Pulmonary and Respiratory Medicine (57 citations) and Biomaterials (16 citations). Erion Dobi has collaborated with scholars based in France, Spain and Italy. Frequent co-authors include Xavier B. Pivot, L. Chaigneau, Fernando Bazán, Antoine Thiery-Vuillemin, Stefano Chong Hun Kim, Cristian Villanueva, Martin Demarchi, Thierry Nguyen, L. Cals and Elsa Curtit. Their work appears in journals such as BMC Cancer, The Breast, Annals of Oncology, Supportive Care in Cancer and Clinical Colorectal Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.